AMD Aktie

 

The CPU is set to play a major role in agentic AI....

The AI infrastructure order boom is spilling into the second half of 2026, and server supply-chain players are turning increasingly upbeat about demand as Nvidia Vera Rubin, AMD Helios, AWS Trainium 3, and Google TPU all move into mass production....

Arm Holdings says its chip architecture has crossed the 50% threshold in the hyperscale cloud market, a milestone in a segment long dominated by Intel and AMD. The SoftBank-backed chip designer is now pushing further into the hardware business itself, even as supply chains strain under the weight of the AI infrastructure buildout....

The ARK Innovation ETF (NYSEARCA:ARKK) has barely moved this year, gaining about 2% year to date through late June and sitting at roughly $78 per share. That stasis hides a violent tug of war inside the portfolio: AMD has more than doubled, up 144% YTD, while Coinbase has shed 34% and Tesla (NASDAQ:TSLA), ARKK's largest ... Tesla's 10% Weight in ARKK Sets Up a Make-or-Break Year for the Innovation ETF...

AMD's stock has run up because of valuation, not business results....

HPE vs. AMD: Which Stock Is the Better Value Option?...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....

New York (www.aktiencheck.de) - AMD-Aktienanalyse von Cantor Fitzgerald: Der Analyst C.J. Muse von Cantor Fitzgerald habe das Kursziel für die Aktie von Advanced Micro Devices Inc. (AMD) (ISIN: US0079031078, WKN: 863186, Ticker-Symbol: AMD, NASDAQ-Symbol: AMD) von 500 auf 700 USD erhlht und und das Rating "overweight" beibehalten. [mehr]...

EMERYVILLE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT, or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced enrollment completion for 4FRONT-2, the second Phase 3 clinical trial in our global program, evaluating 4D-150 in patients with wet age-related macular degeneration (wet AMD)....

New long-term data from diabetic retinopathy and wet AMD programs to be presented at American Society of Retina Specialists (ASRS) 2026 ROCKVILLE, Md., June 29, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the first patient has been dosed in the Phase IIb/III......

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

AMD's MEXT acquisition is an efficiency upgrade for data centers, not a disruption to the AI memory market....

There's a clear answer for today, but a murky one for the future....

Advanced Micro Devices posted record revenue and profit in 2025, and it's flush with cash. Here's a look at whether the tech giant plans to pay dividends....

AMD didn't start buying back stock until more than 50 years after its founding. Here's a look at the company's share repurchase history and treasury balance....

OpenAI had sought to capitalize on the IPO frenzy but is having second thoughts....

Micron sees growth ahead for smartphones and PCs....

Even if OpenAI delays its IPO, AMD stock should be fine....

Shares of ON Semiconductor (NASDAQ:ON) are down 20% in early Friday trading, sliding to $95 after the chipmaker unveiled an all-stock acquisition of Synaptics (NASDAQ:SYNA). The drop erases a meaningful slice of ON stock's recent rally. ON Semiconductor stock entered the session up 119% year to date (YTD), so today's air pocket lands on a ... ON Semiconductor Tumbles 20%: Is It Dragging Down Semiconductor Names Like AMD and Intel?...

Our Advanced Micro Devices (NASDAQ:AMD) call sits on a strong analyst tailwind and a stretched multiple. After a 148.68% year-to-date rally, the question is whether the next leg pays you to chase. Our model says yes, modestly. Our 24/7 Wall St. Price Target Says BUY With Room to Run Metric Value Current Price $532.57 24/7 ... Is AMD a Buy? The Forecast and the 80% Bullish Analyst Wall...